To identify risk factors for left ventricular (LV) dysfunction in right ventricular (RV) pacing in the young.
Introduction
Right ventricular (RV) pacing is associated with asynchronous left ventricular (LV) activation, 1 which can lead to deleterious pathologic remodelling and LV failure. Several recent studies have demonstrated that high percentage of RV apical pacing correlates with morbidity and mortality on heart failure in adults, 2 -4 however, only limited data are available in case of children. Karpawich et al. 5 described histological changes (myofibrillar hypertrophy, fibrosis, fatty deposits) and depressed LV function in paediatric patients with congenital complete atrioventricular block (CAVB) and RV apical pacing. Two multicentre studies reported children with congenital CAVB who developed severe dilated cardiomyopathy. 6, 7 Interestingly, all of those patients have been conventionally paced from a very young age (median 1 and 7 days, respectively). No signs of acute inflammation supporting the hypothesis of an immune-mediated process were found in endomyocardial biopsies. Accidental reports and small series could show positive and partially spectacular benefits from upgrades to biventricular pacing in RV pacing-induced heart failure in children. 8 -10 Finally, two larger multicentre surveys have found a high percentage of pacing-associated cardiomyopathy among congenital heart disease patients subjected to cardiac resynchronization therapy (CRT). 11, 12 Although it is doubtless that a distinct proportion of RV-paced paediatric patients may develop clinically significant LV dysfunction, the incidence of this phenomenon is not known and the risk factors are poorly understood.
Methods Patients
A total of 91 consecutive patients with CAVB, systemic left ventricles, and biventricular circulation who underwent pacemaker implantation between 1984 and 2003 in a single tertiary paediatric cardiac surgery centre serving the whole population of the Czech Republic (10.7 millions of inhabitants) have been retrospectively reviewed. Of these 91 patients, 82 have echocardiographic data and were included in the present study. Forty-one patients had non-surgical and 41 patients surgical CAVB. Demographic data relating to block aetiology and pacing site are summarized in Tables 1 and 2 . Structural heart disease in the non-surgical CAVB group consisted of patent arterial duct in all three cases closed interventionally (n¼ 2) or surgically (n¼ 1). Of these three patients, one had positive, one negative, and one unknown maternal antibody status, respectively.
Pacing
All patients had 100% RV pacing along with complete paced ventricular activation. Table 1 summarizes last pacing modes and sites. Pacing lead positions were assigned according to implantation protocol data and confirmed by available chest X-rays. All RV apical and septal pacing sites were endocardial, and all epicardial pacing leads were placed on the free wall of the RV. Except for one case (change from VVIR to DDD pacing 20 days before last follow-up), all pacing mode and site changes were performed .3 months before the last echocardiographic examination. Thus only last follow-up pacing variables were used for further analysis.
Echocardiography
Echocardiographic data stored on analogue tapes during evaluations performed prior to and immediately after the pacemaker implantation (before discharge from hospital) and at the end of follow-up were analysed. Parasternal M-mode images were used to measure the LV end-diastolic diameter (LVEDD) and end-systolic diameter (LVESD). Measurements were taken at the point of peak diastolic LV free wall outward motion and peak systolic inward motion, respectively, and LV shortening fraction (SF) was calculated according to the following formula: (LVEDD2 LVESD)/LVEDDÂ100. Echocardiographic measurements were compared with the normal values of body weight matched individuals, 13 using the z-score method. Left ventricular dilatation and dysfunction were defined if both SF,26% and LVEDD. þ2z-values were present. Colour Doppler echocardiography was performed for quantifying mitral regurgitation using a four-grade scale. In five patients subjected to CRT LV, end-diastolic and end-systolic volumes were prospectively measured using the Simpson's biplane method and ejection fraction was also calculated.
Statistical analysis
Data are presented as mean (SD) or as median (range). 
Results

Left ventricular size and function
There was a significant decrease in LV SF and increase in the LVEDD at the end of follow-up ( Table 3) . LV SF tends to worsen more in the surgical vs. non-surgical CAVB group between the post-implantation measurement and last follow-up [mean 29 (11) vs. 24 (8)%, respectively, P ¼ 0.052]. Similar tendency has, however, not been observed for the change in LVEDD. The incidence of LV dilatation and dysfunction of patients with available data was found to increase significantly from 1.3% prior to pacemaker implantation and 1.6% immediately after implantation to 13.4% (11 of 82) patients at last follow-up ( Table 3) and differed depending on the pacing site ( Figure 1 ). Although complete echocardiographic data were not available for all follow-up points, all patients with LV dilatation and dysfunction at last follow-up had both pre-and early post-implantation echocardiographic measurements included in the analysis. Detailed clinical and echocardiographic data of the 11 patients with late LV failure are shown in Table 4 . All of these 11 patients had progressive deterioration of LV SF as well as LV dilatation except Patient 2, in whom LV size decreased (but did not normalize) after mitral valve replacement for severe regurgitation. In six of 11 patients, LVEDD increased by .2z-values and SF decreased by .10% from early post-implantation evaluation to last follow-up. No significant haemodynamic or structural abnormalities other than the influence of pacing explaining late LV dysfunctions were identified. Myocardial biopsies were available in two of three patients with non-surgical AV block who reached the defined endpoint of LV dilatation and dysfunction and did not reveal any signs of myocarditis. The findings were, however, consistent with those reported by Karpawich et al. 5 in patients with chronic RV pacing.
Univariate risk factors for late left ventricular dilatation and dysfunction
Patients with late LV dysfunction were significantly younger at pacemaker implantation, had higher degree of baseline mitral regurgitation, and had higher proportion of dual-chamber and epicardial RV free wall pacing. The pre-implantation, early postimplantation, and last follow-up parameter differences are listed in Table 5 . 
Outcome of patients with late left ventricular dilatation and dysfunction
Eight of the 11 patients were in NYHA Class II-IV. One of the 11 patients had to be placed on extracorporeal membrane oxygenation for refractory heart failure and died (Patient 11, Table 4 ).
Another patient was successfully transplanted (Patient 3, Table 4 ). Five patients were resynchronized (Patients 1, 4, 5, 7, and 9, Table 4 ). Four of them by an upgrade to biventricular pacing and the remaining one (Patient 1, Table 4 ) by programming the pacemaker to low intervention rate to allow a narrow QRS escape rhythm to prevail. These five patients showed major reverse remodelling of the LV within 1-18 months of therapy ( Table 6 ). Two of these five patients (Patients 1 and 9) had already been reported in the previous publication. 8 The remaining four of 11 patients are compensated on heart failure medication ( Table 4) .
Discussion
Our data have confirmed the previously published reports on the development of pathologic LV remodelling in a significant proportion of young patients with RV pacing. AB, specific maternal antibodies; Age, age at first pacemaker implantation; AN, anomaly; AVSD/I, incomplete atrioventricular septal defect; CCAVB, congenital complete atrioventricular block; CoA, coarctation of aorta; cong., congenital; CRT, cardiac resynchronization therapy; FUP, length of follow-up in years; HFx, heart failure medication; HTx, heart transplantation; IE, infectious endocarditis; last, last follow-up; LV, left ventricle; LVEDD, left ventricular end-diastolic diameter; MR, mitral regurgitation; MV, mitral valve; NA, not available; P., pacing; PA/IVS, pulmonal atresia with intact ventricular septum; preimp, pre-implantation; postimp, post-implantation; RVA, endocardial right ventricular apex; RVFW, epicardial right ventricular free wall; surg., surgical; ToF, tetralogy of Fallot; TV, tricuspid valve; VSD, ventricular septal defect. LV dilatation and dysfunction (13.4%) is somewhat higher when compared with data published recently (7.4 and 6.0%, respectively). 10, 16 This may be caused by different definitions used to specify LV dysfunction and influenced by a bias introduced through lack of information in nine of 91 originally eligible consecutive patients, who could not be included in our analysis because of insufficient echocardiographic data but are likely not to have developed clinically significant heart failure because not coming to clinical attention. For the first time, our data point to a pacing site-specific risk for LV dysfunction development. The presence of epicardial RV free wall pacing was the only significant and independent multivariable predictor of adverse outcome. One may speculate that epicardial RV free wall pacing may carry more LV dyssynchrony than commonly used endocardial pacing sites. The quality of the retrospectively analysed echocardiographic data was unfortunately not sufficient to prove this hypothesis by measuring mechanical LV dyssynchrony indices and further studies specifically looking at this issue are needed. The results of the analysis may point to additional contributing factors for the development of pacing-induced LV cardiomyopathy based on the presence of high sinus-driven pacing rates associated with young age and a DDD pacing mode. When combined, these risk factors may constitute a vicious circle of a tachycardia-dyssynchrony-mediated cardiomyopathy. 6, 8 Our findings also confirm the benefit of LV resynchronization in symptomatic RV pacing-induced LV dysfunction in children as has been reported previously. 8, 10 Upgrading to biventricular pacing or just switching the pacemaker off to allow an escape narrow QRS rhythm to prevail may lead to successful reverse LV remodelling. The importance of conventional pacing-induced systemic ventricular dysfunction has been recently reported by two published retrospective multicentre studies on CRT in paediatric and congenital heart disease. Pacing-induced ventricular failure was a major indication for CRT ranging from 44.7% 11 to 77.1%.
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The present report has several limitations. First, the retrospective study design did not allow for evaluation of complete echocardiographic data sets. This may have influenced the results of univariate and multivariate analyses. However, serial echocardiographic data were available in all patients reaching the composite endpoint of LV dilatation and dysfunction, thus excluding at least the possibility that already existing pre-implantation dysfunction could have been missed and interpreted as a consequence of pacing during later follow-up. Secondly, measurement of LV SF may not be the best method to reflect the degree of systolic LV dysfunction in the presence of dyssynchrony. However, a decrease in SF along with progressive LV dilatation is, in our opinion, a relatively solid marker of pathologic LV remodelling, and changes in SF were well correlated with changes in LV ejection fraction as measured by the biplane Simpson's method in patients undergoing CRT. Thirdly, LV dysfunction may have been potentially caused by operation in the surgical AV block patients. However, development of LV dilatation and dysfunction has not been significantly different between the nonsurgical and surgical AV block groups and aetiology of AV block has not been identified as a significant risk factor in the statistical analysis. Furthermore, in the published reports 8, 10 as well as in all our patients, LV function was found to improve regardless of AV block aetiology after CRT.
Clinical implications
The results of this study once again stress the need for prosynchronization strategies in conventional cardiac pacing in the young. Several reports have evaluated optimal pacing lead positions in both adults and children. Karpawich et al. have been the first to show preserved LV function and myocardial ultrastructure during pacing from RV septum (proximal His -Purkinje conduction system) when compared with RV apex pacing. 17 -19 Tse et al.
have mapped the RV septum to select a pacing site with the shortest QRS duration. After 18 months of pacing, LV ejection fraction in those patients was significantly higher than in a control group paced from the RV apex. 20 Finally, epicardial LV apical pacing has been shown to carry minimal LV dyssynchrony and the lowest decrease in maximum LV þdP/dt in both an acute animal and human studies 21, 22 and may be a promising substitute to RV epicardial pacing in the young. Thus, there are alternative pacing strategies available that should be studied prospectively in order to better define optimal ventricular lead placement in the paediatric age group. In the presence of a systemic LV, epicardial RV free wall pacing should, however, be avoided whenever possible.
